The latest: Pharmaceutical services outsourcing company WuXi AppTec Co. Ltd. (2359.HK; 603259.SH) reported its revenue rose 71.2% to 8.47 billion yuan ($1.29 billion) in the first quarter, while its operating profit rose 106% to 1.71 billion yuan, according to an announcement late on Monday.

Looking up: The company’s chemistry business was particularly strong for the quarter, with revenue up 102% to 6.12 billion yuan, accounting for 72% of its total, mainly due to an increase in customer volume and the addition of new capacity.

Take Note: Net cash flow from operating activities for the quarter totaled 497 million yuan, down 25.6% from a year earlier, due to a significant increase in material buying to meet growing customer demand.

Digging Deeper: WuXi AppTec is a pharmaceutical outsourcing services provider, covering the entire industry chain from drug discovery to commercialization. It has grown rapidly on big demand from both foreign and domestic drug developers for outsourced R&D and manufacturing services for their activity in the fast-growing China market, and has recorded eight consecutive quarters of revenue growth. The company forecasts that if the Shanghai Covid-19 pandemic is effectively controlled by the end of April, it expects to achieve revenue growth of 63% to 65% in this year’s second quarter, and is confident that it will achieve full-year revenue growth of 65% to 70%.

Market Reaction: WuXi AppTec’s stock rose 3.2% in early trade on Tuesday and closed up 3% at HK$105.9 at the midday break. The shares now trade at the low end of their 52-week range.

Translation by Jony Ho

To subscribe to Bamboo Works free weekly newsletter, click here

Recent Articles

Illustration of Chinese government pumping confidence into stock market

China’s state-driven stocks, and its corporate wars abroad

China's stock market rally is fast approaching its one-year mark, with the benchmark Hang Seng and Shanghai composite indexes both up around 40%. How much longer can it last, especially given the weak state of China's economy? And internet giants Meituan and DiDi have sued each other in Brazil, where they are competing in the takeout dining market. How is this case likely to end up?